C3i is a full-service CDMO with a GMP-validated center with commercial capabilities. We translate groundbreaking research into tangible cell and gene therapies, empowering healthcare providers to combat disease and improve patient outcomes. We have a 15-year expertise with a 99% manufacturing success rate in over 300 clinical productions annually. We meet our clients’ needs from process development to commercialization with our comprehensive analytical testing and clinical CRO services.